MRNA
Moderna, Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth -14.3% ·
share flow -11.4% ·
net new positions -16.7%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | +1 | 102.47K | $19.34M | +1 | n/a |
| Q2 2026 | 147 | +2 | 264.33M | $18.50B | +8 | −5 |
| Q1 2026 | 147 | +3 | 253.55M | $12.87B | +6 | −4 |
| Q4 2025 | 144 | +3 | 257.18M | $7.59B | +5 | −1 |
| Q3 2025 | 18 | +1 | 165.07M | $4.26B | +2 | −2 |
| Q2 2025 | 15 | 0 | 160.48M | $4.43B | +1 | −1 |
| Q1 2025 | 12 | -2 | 69.84M | $1.98B | +1 | −3 |
| Q4 2024 | 14 | -1 | 78.84M | $3.28B | +3 | −4 |
| Q3 2024 | 14 | -2 | 62.86M | $4.20B | +2 | −4 |
| Q2 2024 | 16 | n/a | 65.32M | $7.75B | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Baillie Gifford ✦ | 24.95M | -35.9% | $707.29M | 0.6% | ▼ Trim | 4 | SEC ↗ ×4 |
| 2 | State Street Global Advisors ✦ (passive) | 17.78M | +1.1% | $504.02M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 7.46M | +3.0% | $210.65M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | D. E. Shaw & Co. ✦ | 5.64M | +218.7% | $159.78M | 0.2% | ▲ Add | 3 | SEC ↗ ×2 |
| 5 | Two Sigma Investments ✦ | 4.45M | +570.8% | $126.27M | 0.3% | ▲ Add | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 2.90M | -26.0% | $82.09M | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 7 | Norges Bank ✦ (passive) | 2.74M | -30.5% | $77.64M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 1.76M | +128.1% | $49.90M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 9 | Renaissance Technologies ✦ | 1.36M | +34.6% | $38.56M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 10 | T. Rowe Price ✦ | 642.95K | -40.1% | $18.23M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 11 | Millennium Management ✦ | 148.79K | -86.8% | $4.22M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 15.25K | New | $415,195 | 0.0% | New | 1 | SEC ↗ ×5 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| AQR Capital Management | $415,195 | 0.0% |
Exited
| Bridgewater Associates | $25.19M | was 0.1% |
| Coatue Management | $7.94M | was 0.0% |
| Gotham Asset Management | $2.67M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 717 holders, 306.78M shares, $15.39B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 39.15K sh · $8.64M
Officer · 450 sh · $96,368
Officer · 38.77K sh · $8.28M
Officer · 40.28K sh · $5.88M
Officer · 40.29K sh · $5.81M
Officer · 19.84K sh · $2.67M
Officer · 15.00K sh · $2.02M
Officer · 3.47K sh · $485,766
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology